Zifrosilone

N/A

Report date: 2022/05/16 18:00:15

NME

Base Information

Drug NameZifrosilone

Drug Alias Name齐罗硅酮MDL-73745

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAcetylcholinesterase inhibitors

TargetsAcetylcholinesterase

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A